PRESS RELEASE published on 05/10/2024 at 18:00, 1 year 10 months ago Informations privilégiées / Autres communiqués Annonce mensuelle des actions et droits de vote de Medincell sur Euronext Paris. Medincell développe des médicaments injectables à action prolongée pour divers domaines thérapeutiques Euronext Paris AMF Biopharmaceutique Medincell Médicaments Injectables
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 10 months ago Informations privilégiées / Autres communiqués Les résultats positifs de l'étude de phase 3 SOLARIS démontrent l'efficacité de TV-749, injection sous-cutanée mensuelle pour la schizophrénie par Teva et Medincell Santé Mentale Schizophrénie Medincell TV-749 Teva
PRESS RELEASE published on 05/08/2024 at 12:30, 1 year 10 months ago Inside Information / Other news releases Teva and Medincell announce positive Phase 3 efficacy results from SOLARIS trial evaluating TEV-'749 (olanzapine) as a once-monthly subcutaneous long-acting injectable in adults with schizophrenia Schizophrenia Medincell Teva Phase 3 Efficacy Results SOLARIS Trial
BRIEF published on 05/08/2024 at 09:05, 1 year 10 months ago Medincell Temporarily Suspends its Euronext Paris Listing Euronext Paris Press Release Financial Markets Medincell Share Suspension
BRIEF published on 05/08/2024 at 09:05, 1 year 10 months ago Medincell suspend temporairement sa cotation sur Euronext Paris Euronext Paris Marchés Financiers Communiqué De Presse Médine Partager La Suspension
PRESS RELEASE published on 05/08/2024 at 09:00, 1 year 10 months ago Inside Information / Other news releases Medincell suspends listing of shares on Euronext Paris pending press release. Innovative biopharmaceutical company developing long-acting injectable drugs Euronext Paris Biopharmaceutical Suspension Medincell Long-acting Injectable Drugs
PRESS RELEASE published on 05/08/2024 at 09:00, 1 year 10 months ago Informations privilégiées / Autres communiqués Medincell suspend la cotation de ses actions sur Euronext Paris, en attente de la publication d'un communiqué. Reprise des négociations prévue demain Euronext Paris Cotation Suspension Medincell Communiqué
Published on 03/28/2026 at 01:00, 1 hour 11 minutes ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 1 hour 16 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 1 hour 21 minutes ago "Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 3 hours 26 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 3 hours 41 minutes ago Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/28/2026 at 01:42, 28 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 4 hours 12 minutes ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 21:58, 4 hours 12 minutes ago Kaufman & Broad SA: Mise à disposition du Document d'Enregistrement Universel 2025
Published on 03/27/2026 at 20:08, 6 hours 2 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 6 hours 40 minutes ago Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 19:06, 7 hours 4 minutes ago Mersen : Déclaration des transactions sur actions propres
Published on 03/27/2026 at 18:52, 7 hours 18 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:52, 7 hours 18 minutes ago Crédit Agricole CIB annonce la publication de son Document d’enregistrement universel 2025
Published on 03/27/2026 at 18:40, 7 hours 30 minutes ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
